| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/2009 | CN100488508C Pharmaceutical composition containing tetrahydroisoquinoline compounds |
| 05/20/2009 | CN100488507C Dosage form containing pantoprazole as active ingredient |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488505C Use of Darifenacin and its salts |
| 05/20/2009 | CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 05/20/2009 | CN100488503C Pharmaceutical composition for treating cardiovascular and cerebrovascular disease |
| 05/20/2009 | CN100488502C Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 05/20/2009 | CN100488501C Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyper-permeability or undesired permeability |
| 05/20/2009 | CN100488500C Use of COX-2 inhibitors for preventing immunodeficiency |
| 05/20/2009 | CN100488499C Orally disintegrating tablet of coenzyme Q10 and preparation method thereof |
| 05/20/2009 | CN100488498C Application of turmeric extract in preparation of medicine for preventing and postponing chronic kidney function failure |
| 05/20/2009 | CN100488497C Use of leukotriene in preparing medicament |
| 05/20/2009 | CN100488490C Hemostat agent, method and carrier for applying blood clotting agent |
| 05/20/2009 | CN100488381C Propolis ganoderma lucidum spore, dried black fungus polysaccharide compounded soft capsule and preparing process therefor |
| 05/19/2009 | US7534918 Histone deacetylase inhibitors |
| 05/19/2009 | US7534914 Substituted methyl aryl or heteroaryl amide compounds |
| 05/19/2009 | US7534913 Crystalline form of nateglinide |
| 05/19/2009 | US7534907 Alkyl ester alpha -cyanoacrylate monomers; saleable package containing the monomer and a polymerization initiator or accelerator and a therapeutical agent; internal adhesive that polymerizes in vivo, where the monomer and the resultant polymer are biocompatible and biodegradable |
| 05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| 05/19/2009 | US7534893 Imidazol-2-one compounds useful in the treatment of various disorders |
| 05/19/2009 | US7534887 Thiazoline derivative and use of the same |
| 05/19/2009 | US7534885 Characterized by the formation and isolation of intermediate compounds in salified form; by using the intermediate of the present process in the subsequent reductive passage, it is possible to obtain emtricitabine in a purity that allows its direct crystallization; viricides |
| 05/19/2009 | US7534884 Preparation of pharmaceutical salts |
| 05/19/2009 | US7534871 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 05/19/2009 | US7534859 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 05/19/2009 | US7534817 isolated from the seed fat of Pycnanthus Kombo; potent antioxidant |
| 05/19/2009 | US7534816 mouthwashes; improved two step procedure that controls the generation of impurities and the byproducts; aminopropyl dimethylamino betaine |
| 05/19/2009 | US7534815 Preventive or remedy for hypertension |
| 05/19/2009 | US7534814 Mutilin derivatives and their use as antibacterials |
| 05/19/2009 | US7534813 2-(4-substituted phenoxy)ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate orally coadministered with a decarboxylase inhibitor or a catechol O-methyltransferase inhibitor; improved bioavailability when administered in the colon; sustained release; sleep disorders; nervous system disorders |
| 05/19/2009 | US7534811 Cyclic onium compounds and glucosidase inhibitors |
| 05/19/2009 | US7534810 Crystalline form of atorvastatin sodium or its hydrate; use treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's Disease |
| 05/19/2009 | US7534809 To treat retroviral infections; against drug-resistant forms of the virus; Ethyl 3-bromo-5-chloro-1-(phenylsulfonyl)-1H-indole-2-carboxylate |
| 05/19/2009 | US7534808 Indolylmaleimide derivatives |
| 05/19/2009 | US7534807 infections, burns, sepsis, ulcers, periodontal disease, atherosclerosis, cosmetic and dermatologic conditions, acne, tissue sealing, neoplastic disease or cancer; active agents in photodynamic therapy, luminescent compounds in flow cytometry, solar cells, light harvesting arrays, molecular memory devices |
| 05/19/2009 | US7534805 Imidazole derivatives, their preparation and their use as medicaments |
| 05/19/2009 | US7534804 N-(2-Benzooxazol-2-yl-ethyl)-4-pentyl-benzenesulfonamide; 15-lipoxygenase inhibitors; inflammation; diabetes; vascular restenosis; hypertension; asthma; rheumatiod arthritis; osteoarthritis; cancer; and inflammatory bowel disease |
| 05/19/2009 | US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 05/19/2009 | US7534802 Compounds having 4-pyridylalkylthio group as substituent |
| 05/19/2009 | US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534799 Pyridomorphinans, thienomorphinans and use thereof |
| 05/19/2009 | US7534798 Vanilloid receptor ligands and their use in treatments |
| 05/19/2009 | US7534797 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 05/19/2009 | US7534796 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| 05/19/2009 | US7534795 Compounds and their use related to compositions for treating disease |
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| 05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 05/19/2009 | US7534792 Pyrrolotriazine kinase inhibitors |
| 05/19/2009 | US7534791 e.g. [2-(Benzo[b]furan-3-ylsulfanyl)-benzyl]-methyl-amine; serotonin and noradrenaline reuptake inhibitors; antidepressant, anxiolytic agent, pdychological disorders, analgesic, neurodegenerative diseases |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534789 Enantiomeric pure β agonists, manufacturing and use as a medicament thereof |
| 05/19/2009 | US7534788 Benzofuran and benzothiophene-2-carboxylic acid amide derivatives |
| 05/19/2009 | US7534787 Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds |
| 05/19/2009 | US7534786 Inhibition of tau-tau association |
| 05/19/2009 | US7534785 e.g.1-{3-[5-(4-chlorophenyl)-2-oxo-6H-1,3,4-thiadiazin-3-ylmethyl]phenyl}-3-(1-methylpyrrolidin-3-ylmethyl)urea; inhibitors of tyrosine kinases, in particular Met kinase; antitumor, antiinflammatory agent |
| 05/19/2009 | US7534784 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 05/19/2009 | US7534782 3-(2-Guanidinoacetylamino)pyrrolidin-1-ylcarbonyl]-1-methylpyrrolidin-4-ylthio]-6-[(1R)-1-hydroxyethyl]-1-methyl-1-carbapen-2-em-3-carboxylic acid ethanolate; viricide; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli and Pseudomonas aeruginosa; storage stability |
| 05/19/2009 | US7534781 crystalline powder having a bulk density higher than 0.45 g/ml; better flow characteristics for filling capsules |
| 05/19/2009 | US7534780 Estradiol prodrugs |
| 05/19/2009 | US7534779 a steroidal quinol that is converted to a biologically active estrogen compound via enzyme catalyzed reduction; 2-(1-adamantyl)-estra-1,3,5(10)-triene-3,17 beta -diol; estrogen receptors activator; low lipid solubility; cataract, glaucoma, conjunctivitis, diabetic retinopathy |
| 05/19/2009 | US7534778 (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 05/19/2009 | US7534777 Des-C,D analogs of 1α,25-dihydroxy-19-norvitamin D3 |
| 05/19/2009 | US7534776 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 05/19/2009 | US7534773 reduces the expression of testosterone-repressed prostate message-2 provides therapeutic benefits in the treatment of cancer for example prostate cancer and renal cell cancer; Combined use with taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer |
| 05/19/2009 | US7534771 Tricyclic-nucleoside prodrugs for treating viral infections |
| 05/19/2009 | US7534770 extract of a plant of the family Liliaceae; Aloe vera; can be safely ingested without causing acute hypoglycemia and has a long-term blood glucose level control action to decrease the hemoglobin Alc level |
| 05/19/2009 | US7534769 Cholic acid or deoxycholic acid derivatives can include polypeptides, polynucleotides such as genes and antisense nucleic acids that can modulate cellular activity |
| 05/19/2009 | US7534768 Synergistic combination of loop diuretic and cardiac glycoside; impregnated intraocular/contact lens |
| 05/19/2009 | US7534767 4-amino-7-(2-C-methyl- beta -D-ribofuranosyl)-furo[3,2-d]pyrimidine; 7-amino-3-(2-C-methyl- beta -D-ribofuranosyl)-1H-pyrazolo[4,3-d]pyrimidine; -amino-7-(2-C-methyl- beta -D-ribofuranosyl)-5H-pyrrolo[3,2-d]pyrimidine; hepatitis C virus (HCV) infection |
| 05/19/2009 | US7534766 providing a dosage of tigecycline to a human; obtaining a sample of feces or serum; and extracting such sample to obtain an epimer of a glucuronide metabolite of tigecycline; bactericide; pneumonia, bone and joint infections, catheter-related Neutropenia, |
| 05/19/2009 | US7534613 Methods of treating parkinson's disease using viral vectors |
| 05/19/2009 | US7534593 Crystals of glucokinase and methods of growing them |
| 05/19/2009 | US7534562 Tetrahydrofolate synthetase gene |
| 05/19/2009 | US7534456 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity |
| 05/19/2009 | US7534455 To increase the therapeutic index of doxorubicin, thalidomide, capecitabine, gemcitabine, or oxaliplatin; synergistic mixture of Scutellaria, Glycyrrhiza, Ziziphus and Paeonia extracts with the anticarcinogenic agents |
| 05/19/2009 | US7534450 Promoting metallothioneins by administering a copper-free nutrient supplement containing 50 - 150 mg of zinc, and further containing vitamin B6, pyridoxal-5'-phosphate, vitamin E, vitamin A, vitamin C, selenium, glutathione, taurine, and a mixture of amino acids |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534441 Immunogenic LHRH compositions and methods relating thereto |
| 05/19/2009 | US7534439 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 05/19/2009 | US7534438 Reducing viscosity, cohesion; mixture containing thioreodxin; cystic fibrosis |
| 05/19/2009 | US7534429 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 05/19/2009 | US7534423 administering to said individual an effective amount of either i) recombinant protein CD73 or ii) a cytokine or another factor-being capable of inducing endothelial CD73 expression; inflammation |
| 05/19/2009 | US7534421 Water solubility; photostability; sunscreen agents; ultraviolet radiation B and A absorbers |
| 05/19/2009 | US7534230 Systems and methods for administering a medical regimen |
| 05/19/2009 | CA2611072A1 Novel compounds and uses thereof |
| 05/19/2009 | CA2591917C Analgesic compositions for treating painful conditions of the anal region and uses thereof |
| 05/19/2009 | CA2585691C Enhanced bimatoprost ophthalmic solution |
| 05/19/2009 | CA2521923C Substance exhibiting antidepressant property |
| 05/19/2009 | CA2505990C Palonosetron for the treatment of chemotherapy-induced emesis |
| 05/19/2009 | CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 05/19/2009 | CA2477260C Site specific delivery of co-administered drugs via inhalation |
| 05/19/2009 | CA2468879C Substituted cyclohexane derivatives |
| 05/19/2009 | CA2463947C Montelukast granule formulation |
| 05/19/2009 | CA2441192C The use of lysine for the prevention or treatment of stress-induced diseases |
| 05/19/2009 | CA2407929C Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 05/19/2009 | CA2400784C Therapeutic product, use and formulation thereof |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2388728C Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina |
| 05/19/2009 | CA2387247C Use of neutralizing agents to growth factors for reducing wound scarring |